ACKR1 and prostate carcinoma: Shen et al. (2006) found that the growth of prostate cancer in DARC-deficient mice was more aggressive, compared to wild-type mice, due to the unblocked angiogenesis of tumor cells. However, this link between DARC and malignancy has been debated by one study (Elson et al., 2011).